NANOG expression correlates with differentiation, metastasis and resistance to preoperative adjuvant therapy in oral squamous cell carcinoma

Oncology Letters - Tập 7 Số 1 - Trang 35-40 - 2014
Masahiro Watanabe1, Yuichi Ohnishi2, Hiroshi Inoue3, Masahiro Wato4, Akio Tanaka4, Kenji Kakudo5, Masami Nozaki6
1Osaka Dental University, Hirakata, Japan
2Department of Cell Biology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan ; Second Department of Oral and Maxillofacial Surgery, Osaka Dental University, Hirakata, Osaka 573-1121, Japan.
3Second Department of Oral and Maxillofacial Surgery, Osaka Dental University, Hirakata, Osaka 573-1121, Japan ; Department of Dentistry and Maxillofacial Surgery, Osaka Red Cross Hospital, Osaka 543-8555, Japan.
4Oral Pathology, Osaka Dental University, Hirakata, Osaka 573-1121, Japan.
5Second Department of Oral and Maxillofacial Surgery, Osaka Dental University, Hirakata, Osaka 573-1121, Japan.
6Department of Cell Biology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Chen, 2004, Genome-wide profiling of oral squamous cell carcinoma, J Pathol, 204, 326, 10.1002/path.1640

Pentenero, 2005, Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: a review of the literature, Head Neck, 27, 1080, 10.1002/hed.20275

Myers, 2000, Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes, Otolaryngol Head Neck Surg, 122, 44, 10.1016/S0194-5998(00)70142-2

Chambers, 2003, Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells, Cell, 113, 643, 10.1016/S0092-8674(03)00392-1

Mitsui, 2003, The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells, Cell, 113, 631, 10.1016/S0092-8674(03)00393-3

Cavaleri, 2003, Nanog: a new recruit to the embryonic stem cell orchestra, Cell, 113, 551, 10.1016/S0092-8674(03)00394-5

Pan, 2007, Nanog and transcriptional networks in embryonic stem cell pluripotency, Cell Res, 17, 42, 10.1038/sj.cr.7310125

Ezeh, 2005, Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma, Cancer, 104, 2255, 10.1002/cncr.21432

Meng, 2010, Overexpression of nanog predicts tumor progression and poor prognosis in colorectal cancer, Cancer Biol Ther, 9, 295, 10.4161/cbt.9.4.10666

Xu, 2012, Nanog: a potential biomarker for liver metastasis of colorectal cancer, Dig Dis Sci, 57, 2340, 10.1007/s10620-012-2182-8

Matsuoka, 2012, Role of the stemness factor sox2, oct3/4, and nanog in gastric carcinoma, J Surg Res, 174, 130, 10.1016/j.jss.2010.11.903

Tsai, 2011, Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma, J Oral Pathol Med, 40, 621, 10.1111/j.1600-0714.2011.01015.x

Bourguignon, 2012, Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells, Oncogene, 31, 149, 10.1038/onc.2011.222

Chiou, 2008, Positive correlations of oct-4 and nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma, Clin Cancer Res, 14, 4085, 10.1158/1078-0432.CCR-07-4404

Zhang, 2010, A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy, Cancer Lett, 289, 151, 10.1016/j.canlet.2009.08.010

Sobin, 1997, International Union Against Cancer TNM classification of malignant tumors, 5th edition

Dalerba, 2007, Cancer Stem Cells: Models and Concepts, Annu Rev Med, 58, 267, 10.1146/annurev.med.58.062105.204854

Clarke, 2006, Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells, Cancer Res, 66, 9339, 10.1158/0008-5472.CAN-06-3126

Reya, 2001, Stem cells, cancer, and cancer stem cell, Nature, 414, 105, 10.1038/35102167

Costea, 2006, Cancer stem cells - new and potentially important targets for the therapy of oral squamous cell carcinoma, Oral Dis, 12, 443, 10.1111/j.1601-0825.2006.01264.x

Locke, 2005, Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines, Cancer Res, 65, 8944, 10.1158/0008-5472.CAN-05-0931

Izumiya, 2012, Chemoresistance is associated with cancer stem cell-like properties and epithelial-to-mesenchymal transition in pancreatic cancer cells, Anticancer Res, 32, 3847

Moon, 2011, Nanog-induced dedifferentiation of p53-deficient mouse astrocytes into brain cancer stem-like cells, Biochem Biophys Res Commun, 412, 175, 10.1016/j.bbrc.2011.07.070

Chen, 2006, Lymphatic mapping and sentinel node analysis: current concepts and applications, CA Cancer J Clin, 56, 292, 10.3322/canjclin.56.5.292

Trivedi, 2010, Pathologic evaluation of sentinel lymph nodes in oral squamous cell carcinoma, Head Neck, 32, 1437, 10.1002/hed.21345

Kayahara, 2002, Non-randomized clinical study comparing chemotherapy plus radiotherapy with radiotherapy alone in neoadjuvant therapy for oral cancer, Gan To Kagaku Ryoho, 29, 911